The Metagenomic
Sequencing Market is anticipated to reach USD 1,659.22 Million by 2030 at
17.20% CAGR during the forecast period 2022-2030
Metagenomics
sequencing, also known as environmental or community genomics is an approach
that allows insight to be gained into community biodiversity and function. In
the process of metagenomics sequencing, the DNA of the specified host
microorganism is extracted and cloned directly from the microorganism using
genetic analyses of DNA.
Currently, the metagenomic sequencing market is growing pervasively. The dominant
factors driving this growth include the rising awareness of genetic disorders,
advanced technological platforms, and the availability of improved genomic
tools. Moreover, the continually dropping prices of this process are escalating
the market on the global platform, encouraging people to undergo the genetic
tests.
The function of
metagenomic sequencing which is to sequence the genomes of untargeted cells in
a community in order to elucidate community composition and function helps to
understand the several types of cells in a community and what organisms are
present in their physiology.
Research using the
metagenomic sequencing taps into several fields due to the broad existence of
large microbial communities. For instance; the study of soil microbiota has led
to advances in understanding and treating plant pathogens. Whereas. In human
gut microbiota, the use of metagenomics discovered how common antibiotic genes
are in the gut bacteria.
The market
demonstrates vast opportunities for service providers and companies with a
great scope of expanding to enter the untapped regions by making these
procedures affordable.
Additional factors
fostering the growth of the market include the use of advanced bioinformatics
tools, high throughput screening (HTS) methods, recovery of novel drugs, and
the development of cost-effective technologies such as next-generation
sequencing (NGS).
Major Key
Players:
Global Metagenomic Sequencing Market Players include Enterome Bioscience
(France), GATC Biotech AG (Germany), Aperiomics, Inc. (U.S.), Illumina Inc.
(U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland),
Second Genome Therapeutics (U.S.), SciGenom Labs Pvt. Ltd. (India), Quest
Diagnostics Incorporated (U.S.), GenapSys, Inc. (U.S.), Freenome Inc. (U.S.),
COSMOSID (U.S.), Beijing Genomics Institute (China), Pacific Biosciences
(U.S.), Biomatters Ltd. (New Zealand), Oxford Nanopore Technologies Inc. (UK),
Thermo Fisher Scientific Inc. (U.S.), CLC Bio (Qiagen) (Denmark), DNAStar Inc.
(U.S.), Agilent Technologies Inc. (U.S.), Macrogen Inc. (South Korea), Knome
Inc. (U.S.), and Helicos BioSciences (U.S.) among others.
Segment Analysis
MRFR has segmented the report into four key dynamics
for an easy grasp;
By Technology: Sequencing
and Bioinformatics among others.
By Application :
Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe
Characterization, Biotechnology, Biofuel, Ecology, and Agriculture among
others.
By End-user :
Hospitals, Research Institutes, and Specialized Clinics among
others.
By Regions :
North America, Europe, Asia Pacific, and the Rest-of-the-World (RoW).
Regional Analysis
The North American region leads
the global metagenomic sequencing market owing to the presence of global
players who are focused on introducing the procedures with innovative
technology. Encouraging governmental support for R&D activities in
healthcare and metagenomic sequencing tests is acting as a significant tailwind
that is pushing up the market.
Additional factors encouraging
the growth of the market include increased uptake of advanced technologies in
the next generation sequencing procedures and its increasing applications and
high healthcare expenditures.
The metagenomic sequencing market
in the US backed the increasing demand for metagenomic sequencing, contributes
to the growth of the regional market majorly. Heading with the rising demands
for metagenomic sequencing procedures, the region will create a larger revenue
pocket in the global metagenomic sequencing market by 2023.
Heading with the significant
advancements of technologies and their wide uptake in the medical sector, the
metagenomic sequencing market in the European region holds the second position
in terms of size.
Moreover, the presence of a
flourishing medical devices market and rising healthcare expenditure in the
region will facilitate the growth of the market. Also, factors such as support
and funding from public & private sectors for research & development
impacts the market growth in the region positively.
Furthermore, the availability of
low-cost metagenomic and NGS procedures and their rising adoption by research
laboratories are driving the growth of this market.
The Asia Pacific region heading
with the increasing prevalence of genetic disorders has emerged as a promising
market for metagenomic sequencing. The large unmet clinical needs are
attracting the foreign investors and global players to focus on this region to
expand the network that is helping them to capture major share of the market.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
